Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Galliverti, Gabriele"" wg kryterium: Autor


Wyświetlanie 1-18 z 18
Tytuł :
Advancing immunotherapy for HPV-related cancers: Improving therapeutic vaccination approaches and understanding the immunosuppressive role of myeloid cells
Autorzy :
Galliverti, Gabriele
Pokaż więcej
Tytuł :
Corrigendum: Advances in pancreatic islet monolayer culture on glass surfaces enable super-resolution microscopy and insights into beta cell ciliogenesis and proliferation
Autorzy :
Phelps, Edward A.
Cianciaruso, Chiara
Santo-Domingo, Jaime
Pasquier, Miriella
Galliverti, Gabriele
Piemonti, Lorenzo
Berishvili, Ekaterine
Burri, Olivier
Wiederkehr, Andreas
Hubbell, Jeffrey A.
Baekkeskov, Steinunn
Pokaż więcej
Temat :
Corrigenda
Źródło :
Scientific Reports. 7
Tytuł :
Matrix-binding checkpoint immunotherapies enhance antitumor efficacy and reduce adverse events.
Autorzy :
Jun Ishihara
Kazuto Fukunaga
Ako Ishihara
Larsson, Hans M.
Potin, Lambert
Hosseinchi, Peyman
Galliverti, Gabriele
Swartz, Melody A.
Hubbell, Jeffrey A.
Pokaż więcej
Temat :
TUMOR immunology
IMMUNOTHERAPY
TUMOR treatment
ADVERSE health care events
IMMUNOGLOBULINS
HEALTH outcome assessment
PREVENTION
Źródło :
Science Translational Medicine; 11/8/2017, Vol. 9 Issue 415, p1-14, 14p
Czasopismo naukowe
Tytuł :
Vaccination with a nanoparticle E7 vaccine can prevent tumor recurrence following surgery in a human papillomavirus head and neck cancer model.
Autorzy :
Domingos-Pereira S; Department of Urology, Lausanne University Hospital and University of Lausanne, Lausanne, Swizterland.
Roh V; Departmentof Otolaryngology-Head and Neck Surgery, Lausanne University Hospital and University of Lausanne, Lausanne, Swizterland.
Hiou-Feige A; Departmentof Otolaryngology-Head and Neck Surgery, Lausanne University Hospital and University of Lausanne, Lausanne, Swizterland.
Galliverti G; Swiss Institute for Experimental Cancer Research, School of Life Sciences, EPFL, Lausanne, Switzerland.
Simon C; Departmentof Otolaryngology-Head and Neck Surgery, Lausanne University Hospital and University of Lausanne, Lausanne, Swizterland.
Tolstonog GV; Departmentof Otolaryngology-Head and Neck Surgery, Lausanne University Hospital and University of Lausanne, Lausanne, Swizterland.
Nardelli-Haefliger D; Department of Urology, Lausanne University Hospital and University of Lausanne, Lausanne, Swizterland.
Pokaż więcej
Źródło :
Oncoimmunology [Oncoimmunology] 2021 Apr 13; Vol. 10 (1), pp. 1912473. Date of Electronic Publication: 2021 Apr 13.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Myeloid Cells Orchestrate Systemic Immunosuppression, Impairing the Efficacy of Immunotherapy against HPV Cancers.
Autorzy :
Galliverti G; Swiss Institute for Experimental Cancer Research, School of Life Sciences, Swiss Federal Institute of Technology Lausanne (EPFL), Lausanne, Switzerland.; Institute of Bioengineering, Swiss Federal Institute of Technology Lausanne (EPFL), Lausanne, Switzerland.
Wullschleger S; Swiss Institute for Experimental Cancer Research, School of Life Sciences, Swiss Federal Institute of Technology Lausanne (EPFL), Lausanne, Switzerland.; Swiss Cancer Center Leman (SCCL), Lausanne, Switzerland.
Tichet M; Swiss Institute for Experimental Cancer Research, School of Life Sciences, Swiss Federal Institute of Technology Lausanne (EPFL), Lausanne, Switzerland.
Murugan D; Department of Cell, Developmental & Cancer Biology, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.
Zangger N; Swiss Institute for Experimental Cancer Research, School of Life Sciences, Swiss Federal Institute of Technology Lausanne (EPFL), Lausanne, Switzerland.; Bioinformatics Core Facility, SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland.; Translational Bioinformatics and Statistics, Swiss Cancer Center Lausanne, Lausanne, Switzerland.; Department of Oncology, University of Lausanne, Lausanne, Switzerland.
Horton W; Computational Biology Program, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.
Korman AJ; Bristol-Myers Squibb Company, Immuno-oncology Research, Redwood City, California.
Coussens LM; Department of Cell, Developmental & Cancer Biology, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.
Swartz MA; Institute for Molecular Engineering, University of Chicago, Chicago, Illinois.; The Ben May Department for Cancer Research, University of Chicago, Chicago, Illinois.
Hanahan D; Swiss Institute for Experimental Cancer Research, School of Life Sciences, Swiss Federal Institute of Technology Lausanne (EPFL), Lausanne, Switzerland. .; Swiss Cancer Center Leman (SCCL), Lausanne, Switzerland.
Pokaż więcej
Źródło :
Cancer immunology research [Cancer Immunol Res] 2020 Jan; Vol. 8 (1), pp. 131-145. Date of Electronic Publication: 2019 Nov 26.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Antineoplastic Agents, Immunological/*pharmacology
CD8-Positive T-Lymphocytes/*immunology
Myeloid Cells/*immunology
Papillomaviridae/*immunology
Papillomavirus Infections/*immunology
Papillomavirus Vaccines/*immunology
Uterine Cervical Neoplasms/*immunology
Animals ; CTLA-4 Antigen/antagonists & inhibitors ; Disease Models, Animal ; Drug Synergism ; Female ; Humans ; Immunosuppression ; Immunotherapy/methods ; Mice ; Myeloid Cells/drug effects ; Nanoparticles/administration & dosage ; Papillomavirus E7 Proteins/immunology ; Papillomavirus E7 Proteins/metabolism ; Papillomavirus Infections/drug therapy ; Papillomavirus Infections/virology ; Papillomavirus Vaccines/administration & dosage ; Programmed Cell Death 1 Receptor/antagonists & inhibitors ; Tumor Microenvironment ; Uterine Cervical Neoplasms/drug therapy ; Uterine Cervical Neoplasms/pathology ; Uterine Cervical Neoplasms/virology
Czasopismo naukowe
    Wyświetlanie 1-18 z 18

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies